Guidelines for the management of hemophilia

@article{Srivastava2013GuidelinesFT,
  title={Guidelines for the management of hemophilia},
  author={A Srivastava and Andrew Brewer and Eveline P. Mauser-Bunschoten and Nigel S. Key and Steve Kitchen and Adolfo Llin{\'a}s and C. A. Ludlam and Johnny N Mahlangu and Kathy Mulder and Man-Chiu Poon and Alison Street},
  journal={Haemophilia},
  year={2013},
  volume={19}
}
Hemophilia is a rare disorder that is complex to diagnose and to manage. These evidence‐based guidelines offer practical recommendations on the diagnosis and general management of hemophilia, as well as the management of complications including musculoskeletal issues, inhibitors, and transfusion‐transmitted infections. By compiling these guidelines, the World Federation of Hemophilia aims to assist healthcare providers seeking to initiate and/or maintain hemophilia care programs, encourage… 
Guidelines for the management of haemophilia in Egypt
TLDR
These guidelines are based primarily on the WFH Guidelines for the Management of Hemophilia and aim to address unmet needs and local requirements in the Egyptian setting.
Review of Hemophilia A and B and Perioperative Management in Dentistry
TLDR
This chapter reviews the pathophysiology, clinical presentation, patient evaluation, and basics of medical management of hemophilia with an emphasis given to the dental management of patients with hemophiliary A and B.
Current management of hemophilia B: recommendations, complications and emerging issues
TLDR
The current management of hemophilia B patients is reviewed, analyzing the results of the most important clinical trials and the more recent advances in the production of new FIX molecules aimed at the improvement of the clinical management of such patients.
Hemophilia management in transfusion medicine.
  • M. Poon, R. Card
  • Medicine
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
  • 2012
The hemophilias and their clinical management.
  • N. Josephson
  • Medicine
    Hematology. American Society of Hematology. Education Program
  • 2013
TLDR
Evidence of improved clinical results from primary prophylaxis started in young patients with severe hemophilia A and a minimal bleeding history is presented and controversies and clinical evidence related to approaches for tolerance induction are reviewed.
Issues in pediatric haemophilia care
TLDR
Quality of life has become in the western countries the primary objective of the process of providing care, thus all the strategies (psychotherapy, physiotherapy, community life), not just the infusion of the missing factor, should be activated for the patient and family to give them the perception of being healthy.
Sequelae of repeated lesions in persons with hemophilia.
  • F. Querol
  • Medicine, Psychology
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2019
TLDR
The World Federation of Hemophilia publishes guidelines as well as general and more specific treatment recommendations that are addressed to patients and their family members, as the prevention of the sequelae of hemophilia requires active patient collaboration and an awareness of the available prophylaxis treatments.
Hemophilia: A Review of Perioperative Management for Cardiac Surgery.
TLDR
A narrative review and framework for the perioperative management of patients with hemophilia A and B undergoing cardiac surgery is provided.
Implementation of Evidence-Based Care in the Sickle Cell and Hemophilia Patient Population
TLDR
Quality improvement interventions have significantly improved outcomes related to the effective and timely management of acute vaso-occlusive crises (VOC), reducing the frequency of VOC necessitating hospitalization by administration of hydroxyurea, prevention of stroke, and reducing infections such as influenza.
Hemophilia A in Females: Considerations for Clinical Management
TLDR
The cases described illustrate the clinical variability and presentation of hemophilia in females and highlight the importance of a timely diagnosis, effective management, and monitoring.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 344 REFERENCES
Modern treatment of haemophilia.
TLDR
The present review article summarizes the discussions and recommendations made by the participants and discusses current and future approaches to the management of haemophilia and its complications, including prospects for genetic technology and gene therapy in developed and developing countries.
World Federation of Hemophilia.
TLDR
The World Federation of Hemophilia (WFH) is an international nonprofit organization of medical and nonmedical volunteers dedicated to improving the quality of musculoskeletal care of individuals with hemophilia and related disorders.
Emergency care of the hemophiliac patient.
Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy
TLDR
These guidelines provide specific recommendations for the choice of the product according to updated scientific evidence, and advice on optimal dosages for the treatment of rare bleeding disorders.
Orthopedic management of hemophilia.
TLDR
Patients with severe hemophilia may develop chronic synovitis and arthropathy best treated with more invasive means, and radioactive synovectomy performed at select hemophiliary centers and arthroscopic or open synoveCTomy are helpful for chronic, activesynovitis.
Emergency department care for patients with hemophilia and von Willebrand disease.
Perinatal management of newborns with haemophilia
The dawn of potentially curative strategies for haemophilia, advances in gene diagnosis and the availability of safer clotting factor concentrates for treatment and prophylaxis make it imperative
The management of cardiovascular diseases in patients with hemophilia.
TLDR
Treatment of cardiovascular disease reflects the evolving scenario in which clinicians who treat hemophilia will have to extend their interactions with other specialists to confront the new challenges of the comprehensive care of aging hemophilic patients.
Haemophilias A and B
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high‐titre inhibitors
TLDR
These guidelines provide a generalized methodology to guide the treatment of problem bleeds in patients with severe haemophilia A and inhibitors, and emphasize changing treatment at the first sign of an inadequate haemostatic response.
...
1
2
3
4
5
...